These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 23279938)
41. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery. Sajeesh S; Sharma CP Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846 [TBL] [Abstract][Full Text] [Related]
42. β-cyclodextrin chitosan-based hydrogels with tunable pH-responsive properties for controlled release of acyclovir: design, characterization, safety, and pharmacokinetic evaluation. Malik NS; Ahmad M; Alqahtani MS; Mahmood A; Barkat K; Khan MT; Tulain UR; Rashid A Drug Deliv; 2021 Dec; 28(1):1093-1108. PubMed ID: 34114907 [TBL] [Abstract][Full Text] [Related]
43. Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain. Pillay S; Pillay V; Choonara YE; Naidoo D; Khan RA; du Toit LC; Ndesendo VM; Modi G; Danckwerts MP; Iyuke SE Int J Pharm; 2009 Dec; 382(1-2):277-90. PubMed ID: 19703530 [TBL] [Abstract][Full Text] [Related]
44. Antiviral activities of methylated nordihydroguaiaretic acids. 2. Targeting herpes simplex virus replication by the mutation insensitive transcription inhibitor tetra-O-methyl-NDGA. Chen H; Teng L; Li JN; Park R; Mold DE; Gnabre J; Hwu JR; Tseng WN; Huang RC J Med Chem; 1998 Jul; 41(16):3001-7. PubMed ID: 9685239 [TBL] [Abstract][Full Text] [Related]
45. Safety and efficacy of amphiphilic beta-cyclodextrin nanoparticles for paclitaxel delivery. Bilensoy E; Gürkaynak O; Doğan AL; Hincal AA Int J Pharm; 2008 Jan; 347(1-2):163-70. PubMed ID: 17689901 [TBL] [Abstract][Full Text] [Related]
46. In vitro antiviral activity of distamycin A against clinical isolates of herpes simplex virus 1 and 2 from transplanted patients. Matteoli B; Bernardini S; Iuliano R; Parenti S; Freer G; Broccolo F; Baggiani A; Subissi A; Arcamone F; Ceccherini-Nelli L Intervirology; 2008; 51(3):166-72. PubMed ID: 18663321 [TBL] [Abstract][Full Text] [Related]
47. Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir. Masuda T; Yoshihashi Y; Yonemochi E; Fujii K; Uekusa H; Terada K Int J Pharm; 2012 Jan; 422(1-2):160-9. PubMed ID: 22079714 [TBL] [Abstract][Full Text] [Related]
48. Novel benzimidazo[2,1-c][1,4]thiazinone derivatives with potent activity against HSV-1. Galal SA; El-Naem SI; El-Nezhawy AO; Ali MA; El-Diwani HI Arch Pharm (Weinheim); 2011 Apr; 344(4):255-63. PubMed ID: 21469175 [TBL] [Abstract][Full Text] [Related]
49. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Khalil SK; El-Feky GS; El-Banna ST; Khalil WA Carbohydr Polym; 2012 Oct; 90(3):1244-53. PubMed ID: 22939337 [TBL] [Abstract][Full Text] [Related]
50. Antiviral properties of 3-quinolinecarboxamides: a series of novel non-nucleoside antiherpetic agents. Wentland MP; Perni RB; Dorff PH; Brundage RP; Castaldi MJ; Carlson JA; Bailey TR; Aldous SC; Carabateas PM; Bacon ER; Kullnig RK; Young DC; Woods MG; Kingsley SD; Ryan KA; Rosi D; Drozd ML; Dutko FJ Drug Des Discov; 1997 May; 15(1):25-38. PubMed ID: 9332829 [TBL] [Abstract][Full Text] [Related]
51. Highly monodispersed gold nanoparticles synthesis and inhibition of herpes simplex virus infections. Halder A; Das S; Ojha D; Chattopadhyay D; Mukherjee A Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():413-421. PubMed ID: 29752114 [TBL] [Abstract][Full Text] [Related]
52. Paclitaxel loaded nanosponges: in-vitro characterization and cytotoxicity study on MCF-7 cell line culture. Ansari KA; Torne SJ; Vavia PR; Trotta F; Cavalli R Curr Drug Deliv; 2011 Mar; 8(2):194-202. PubMed ID: 21235471 [TBL] [Abstract][Full Text] [Related]
53. Preparation and evaluation of N-caproyl chitosan nanoparticles surface modified with glycyrrhizin for hepatocyte targeting. Lin A; Chen J; Liu Y; Deng S; Wu Z; Huang Y; Ping Q Drug Dev Ind Pharm; 2009 Nov; 35(11):1348-55. PubMed ID: 19832635 [TBL] [Abstract][Full Text] [Related]
54. β-Cyclodextrin-grafted on multiwalled carbon nanotubes as versatile nanoplatform for entrapment of guanine-based drugs. Iannazzo D; Mazzaglia A; Scala A; Pistone A; Galvagno S; Lanza M; Riccucci C; Ingo GM; Colao I; Sciortino MT; Valle F; Piperno A; Grassi G Colloids Surf B Biointerfaces; 2014 Nov; 123():264-70. PubMed ID: 25300473 [TBL] [Abstract][Full Text] [Related]
55. Preparation and characterization of poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) (PHBHHX) based nanoparticles for targeted cancer therapy. Kılıçay E; Demirbilek M; Türk M; Güven E; Hazer B; Denkbas EB Eur J Pharm Sci; 2011 Oct; 44(3):310-20. PubMed ID: 21884788 [TBL] [Abstract][Full Text] [Related]
56. Co-encapsulation of acyclovir and curcumin into microparticles improves the physicochemical characteristics and potentiates in vitro antiviral action: Influence of the polymeric composition. Reolon JB; Brustolin M; Accarini T; Viçozzi GP; Sari MHM; Bender EA; Haas SE; Brum MCS; Gündel A; Colomé LM Eur J Pharm Sci; 2019 Apr; 131():167-176. PubMed ID: 30790703 [TBL] [Abstract][Full Text] [Related]